CVS Health Co. (NYSE:CVS) Shares Sold by Bond & Devick Financial Network Inc.

Bond & Devick Financial Network Inc. reduced its stake in shares of CVS Health Co. (NYSE:CVS) by 7.6% during the 3rd quarter, Holdings Channel.com reports. The fund owned 7,669 shares of the pharmacy operator’s stock after selling 632 shares during the quarter. Bond & Devick Financial Network Inc.’s holdings in CVS Health were worth $482,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GSA Capital Partners LLP acquired a new stake in shares of CVS Health in the 1st quarter valued at about $536,000. Meeder Advisory Services Inc. lifted its stake in CVS Health by 6.8% in the first quarter. Meeder Advisory Services Inc. now owns 14,557 shares of the pharmacy operator’s stock valued at $1,161,000 after buying an additional 926 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in shares of CVS Health by 2.6% in the first quarter. QRG Capital Management Inc. now owns 136,676 shares of the pharmacy operator’s stock valued at $10,901,000 after acquiring an additional 3,476 shares during the period. Baron Wealth Management LLC grew its position in shares of CVS Health by 7.0% during the first quarter. Baron Wealth Management LLC now owns 4,900 shares of the pharmacy operator’s stock worth $391,000 after acquiring an additional 322 shares during the last quarter. Finally, Neumann Capital Management LLC increased its holdings in shares of CVS Health by 4.4% in the 1st quarter. Neumann Capital Management LLC now owns 44,616 shares of the pharmacy operator’s stock valued at $3,559,000 after acquiring an additional 1,900 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 0.6 %

Shares of CVS stock opened at $55.88 on Monday. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The business has a fifty day simple moving average of $59.56 and a 200-day simple moving average of $59.06. The stock has a market cap of $70.32 billion, a P/E ratio of 14.10, a P/E/G ratio of 0.88 and a beta of 0.55.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the prior year, the firm earned $2.21 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, analysts forecast that CVS Health Co. will post 5.63 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.76%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Mizuho lowered their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Barclays dropped their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday. Deutsche Bank Aktiengesellschaft decreased their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. UBS Group boosted their target price on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Nine analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $73.00.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.